Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
about
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.Synthesis, characterization, applications, and challenges of iron oxide nanoparticles.Impact of semi-solid formulations on skin penetration of iron oxide nanoparticlesThe impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study.The Effect of Co0.2Mn0.8Fe2O4 Ferrite Nanoparticles on the C2 Canine Mastocytoma Cell Line and Adipose-Derived Mesenchymal Stromal Stem Cells (ASCs) Cultured Under a Static Magnetic Field: Possible Implications in the Treatment of Dog Mastocytoma.Effects of silver nanoparticles on neonatal testis development in micePreclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeysAntibody fragments as nanoparticle targeting ligands: a step in the right directionCD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles.3-Aminopropylsilane-modified iron oxide nanoparticles for contrast-enhanced magnetic resonance imaging of liver lesions induced by Opisthorchis felineus.Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells.Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier.Nanoparticles for imaging and treatment of metastatic breast cancer.Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI.Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.Gadolinium-based layered double hydroxide and graphene oxide nano-carriers for magnetic resonance imaging and drug delivery.Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes.iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.Toxicity and Applications of Internalised Magnetite Nanoparticles Within Live Paramecium caudatum Cells.Iron-gold alloy nanoparticles serve as a cornerstone in hyperthermia-mediated controlled drug release for cancer therapyAdvantages and Limitations of Current Techniques for Analyzing the Biodistribution of NanoparticlesNon-calorimetric determination of absorbed power during magnetic nanoparticle based hyperthermia
P2860
Q26779017-7DB6FD8B-152D-412E-B2C5-BF6D9ADE074FQ27014954-2499F49E-BC1F-4E16-8E8C-5C300555DD92Q29248260-1BF8EAC1-108E-42B3-B998-EFFF429B2FC9Q30994212-B2C67F57-4401-4BD6-BE3C-66F1D05A4DFBQ33695224-1F26BEE1-EC37-424D-8135-8FC1B96C1742Q36142521-3DDA9915-A6B8-417F-B324-1F227E51E7F9Q36240694-09AB261C-8C09-4A67-B622-1A7512003DBBQ36357291-0AC999E9-C2F7-4450-A10F-DD862FD61D1FQ36882988-DFE794E1-FCA5-406C-8C57-E91299BA27F2Q37248674-6E469392-789D-4CD8-9C44-08654BDF5AB2Q37504779-E9B349A1-69D1-44B6-95AF-781EAD9AEAE0Q38698236-E0AE8828-01D0-476D-88B1-4498BF7C15D0Q38842983-F9BC290C-59DD-4041-8EFD-01C386A77F73Q39202721-265741EF-3C71-437B-A2DC-51D73FDCE897Q40952243-F83B38D8-B9AD-4A79-9F80-EFD94352E3B8Q41103676-A00A6F8B-10A1-4533-BE41-933F6BD98D2AQ42877873-F79A6C4D-BAC4-4BDB-A32B-0A8A1424055EQ43376027-D75CA11B-0C22-4EBE-A667-9E8C0AC2A2EDQ47262466-11C7203F-8B99-4F90-AABC-1639F484E28AQ47409412-60801A18-AB43-43F5-ACFB-BEC90A589813Q48540669-CCE802D6-5014-4E02-9336-64F3318D706EQ49319605-9CA7E406-83A9-4E2C-9FAD-EC04BFDC8EA3Q50047453-BB2B671A-A58A-4BBC-80F7-E6FF0EEF4C29Q55073008-345EDC29-97E6-4D2A-B35B-53F2A5663B5CQ55085830-EAF792D6-9492-4394-AD97-ECB77E01AB50Q57074386-92AA729F-E623-4FE9-A3E8-728FA7B0B4B2Q57181636-3E5ACEAD-4648-4BBE-9149-E3CAC72EDF4EQ58714212-C7FA78BA-182A-4589-B619-0396BBF5BFC8
P2860
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@ast
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@en
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@nl
type
label
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@ast
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@en
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@nl
prefLabel
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@ast
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@en
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@nl
P2860
P921
P3181
P356
P1476
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
@en
P2093
Joan Estelrich
Maria Antònia Busquets
P2860
P304
P3181
P356
10.2147/IJN.S76501
P407
P577
2015-03-06T00:00:00Z